Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation

Nancy M. Hardy, MD, Deborah Citrin, MD, Frances T. Hakim, PhD, Daniele N. Avila, CRNP, Bazetta Blacklock-Schuver, RN, Stephanie Cotton, RN, Monica Cho, Daniel H. Fowler, MD, Juan C. Gea-Banacloche, MD, Noa G. Holtzman, MD, Karen A. Kurdziel, MD, Sarfraz Memon, MD, Steven Z. Pavletic, MD, Stefania Pittaluga, MD PhD, Jeremy J. Rose, BA, Claude Sportes, MD, Jennifer S. Wilder, RN, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2015) 126 (23): 1962.

https://doi.org/10.1182/blood.V126.23.1962.1962

Published: 2015

Journal Articles

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

Blood (2013) 122 (25): 4129–4139.

https://doi.org/10.1182/blood-2013-08-519413

Published: 2013

Includes: Supplemental data

Journal Articles

Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)

Nishant Tageja, MD, Neha Korde, MD, Constance Yuan, MD, PhD, Kristen Cole, RN, Jennifer Hsu, RN, Sheila Phang, RN, Daniele N. Avila, CRNP, Tiffany Taylor, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Hanh Khuu, MD, Maryalice Stetler-Stevenson, MD, PhD, Susan F. Leitman, MD, Ola Landgren, MD, PhD, Claude Sportes, MD

Blood (2013) 122 (21): 2030.

https://doi.org/10.1182/blood.V122.21.2030.2030

Published: 2013

Journal Articles

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2013) 122 (21): 151.

https://doi.org/10.1182/blood.V122.21.151.151

Published: 2013

Journal Articles

Utility Of An Algorithm For Use Of Plerixafor In Filgrastim-based Hematopoietic Progenitor Cell Mobilization In Patients With Plasma Cell Myeloma Treated With Carfilzomib-Lenalidomide-Dexamethasone.

Susan F. Leitman, MD, Nishant Tageja, MD, Neha Korde, MD, Yu Ying Yau, RN, Sheila Phang, RN, Jennifer Hsu, RN, Kristin Cole, RN, Hanh Khuu, MD, Ola Landgren, MD, PhD, Claude Sportes, MD

Blood (2013) 122 (21): 906.

https://doi.org/10.1182/blood.V122.21.906.906

Published: 2013

Journal Articles

Phase 2 clinical trial of rapamycin-resistant donor CD4 + Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation

Blood (2013) 121 (15): 2864–2874.

https://doi.org/10.1182/blood-2012-08-446872

Published: 2013

Includes: Supplemental data

Journal Articles

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

Blood (2012) 120 (21): 471.

https://doi.org/10.1182/blood.V120.21.471.471

Published: 2012

Journal Articles

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Blood (2011) 118 (21): 4074.

https://doi.org/10.1182/blood.V118.21.4074.4074

Published: 2011

Journal Articles

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Blood (2011) 117 (22): 5835–5849.

https://doi.org/10.1182/blood-2010-11-316745

Published: 2011

Includes: Supplemental data

Journal Articles

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Blood (2010) 116 (21): 521.

https://doi.org/10.1182/blood.V116.21.521.521

Published: 2010

Journal Articles

Safety and Efficacy of Cytotoxic Chemotherapy after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Hematologic Malignancy.

Nancy M. Hardy, MD, Jeanne Odom, RN, Kelly Snow, RN, Robert Dean, MD, Steven Pavletic, MD, Claude Sportes, MD, Ronald Gress, MD, Daniel H. Fowler, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 5333.

https://doi.org/10.1182/blood.V108.11.5333.5333

Published: 2006

Journal Articles

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel Fowler, MD, Wyndham H. Wilson, MD, PhD, Frances Hakim, PhD, Seth Steinberg, PhD, Jeanne Odom, RN, Catherine Chow, MD, Claude Sportes, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD, Nancy M. Hardy, MD, Ronald Gress, MD, Michael R. Bishop

Blood (2006) 108 (11): 317.

https://doi.org/10.1182/blood.V108.11.317.317

Published: 2006

Journal Articles

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Claude Sportes, MD, Michael Krumlauf, RN, Rebecca Babb, RN, Ladan Foruraghi, RN, Janine Daub, RN, Daniele Avila, RN, Catherine Chow, MD, Hua Zhang, PhD, Kevin Chua, PhD, Terry Fry, MD, Sarfraz Memon, PhD, Frances Hakim, PhD, Thomas Fleisher, MD, Margaret Brown, BSN, Julie Engel, PhD, Renaud Buffet, MD, Michel Morre, DVM, Ronald Gress, MD, Crystal Mackall, MD

Blood (2006) 108 (11): 871.

https://doi.org/10.1182/blood.V108.11.871.871

Published: 2006

Journal Articles

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel H. Fowler, MD, Nancy M. Hardy, MD, Jeanne Odom, RN, Kathleen Castro, MSN, Michael Krumlauf, RN, Frances T. Hakim, PhD, Claude Sportes, MD, Ronald E. Gress, MD, Michael R. Bishop

Blood (2005) 106 (11): 3662.

https://doi.org/10.1182/blood.V106.11.3662.3662

Published: 2005

NARROW

Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

Utility Of An Algorithm For Use Of Plerixafor In Filgrastim-based Hematopoietic Progenitor Cell Mobilization In Patients With Plasma Cell Myeloma Treated With Carfilzomib-Lenalidomide-Dexamethasone.

Phase 2 clinical trial of rapamycin-resistant donor CD4 + Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Safety and Efficacy of Cytotoxic Chemotherapy after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Hematologic Malignancy.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only